sional responsibility . . . an opportunity to increase his [the pharmacist's] usefulness as a member of the health team." The number of review articles in the pharmaceu tical literature and the inclusion of "Drug Interactions" in continuing education programs attest to the current popularity of the subject.
Literally, drug interaction is the phenomenon of two or more drugs interacting in such manner that the effec tiveness or toxicity of one or more of the drugs is altered. Practically, the subject of drug interaction has been broadened to include many substances, both foreign (e.g., insecticides, food) and endogenous (e.g., choles terol, catecholamines) which respectively may either alter the effectiveness of a drug or whose levels in the body fluids may be changed. A complex part of the "drug interaction" literature involves the effect of drugs on results of laboratory tests. In addition, the many physiological, pathological and genetic factors which affect drug action will also affect drug interactions. These factors have a crucial bearing on the incidence and clinical significance of drug interactions-a fact which the pharmacist must always keep in mind.
Medicine is not an exact science; hence, drug interac tions cannot be easily represented by a chart. There is no short-cut for knowledge, and if the pharmacist is to "increase his usefulness" then he must also assimilate, evaluate and disseminate knowledge about the subject. While reviewers may summarize the literature and charts may tabulate the data, the pharmacist faced with a potential drug interaction must know why there is a potential interaction, what the chances are for the inter action to occur, how important it is to the patient's health and what can or should be done about it. To do this the pharmacist must be able to refer to original re ports in the literature or good abstracts thereof, correlate this with his prior knowledge of drug actions and provide an informed opinion on the subject.
The currently available reviews of drug interactions (mine' included) are fraught with inaccuracies, misin terpretations and misleading data. Many of the most quoted interactions (e.g., increased toxicity of metho trexate by aspirin, enhanced effect of tolbutamide by sulfisoxazole) are the poorest in documentation. Reviews often devote as much space to one questionable case history as they do to a well-conducted research study. No differentiation is made between animal data and human data, even when the original article pointedly denotes species differences, particularly in drug metabo lism. Finally, some reviews provide no references or else list other reviews as references. By the time the searcher finds the original article he not only is frustrated, but he finds that the data have been distorted and have little resemblence to the interaction reported in the review.
The incidence and clinical significance of drug inter actions are extremely difficult to determine. At present, the only indicator of incidence is the number of reports in the clinical literature. Evaluation of these reports also may indicate clinical significance although the contro versy over the importance of the potentiation of warfarin by quinidine indicates that even the experts disagree. We need a research project to comb the literature for those interactions which are potentially most dangerous to the patient and those which may do serious harm and occur frequently. This would probably result in a fairly small and manageable list.
The pharmacist, in communicating information about interactions, must have not only available the informa tion, he must also have perspective on the clinical use of the drug, the hazard involved, and a tactful manner in presenting the data. Drug interactions have been called therapeutic incompatibilities. This is exactly the connota tion that must be avoided. Drugs which interact are used together-and often with no problem. The important part is that the physician realize that there is the potential for an interaction and the possible alteration of effect. Very seldom does the situation arise where two drugs cannot be used together. Indiscretion in communication can change the pharmacist from a valuable member of the health team to an "ignorant pest." EDWARD A. HARTSHORN, Ph.D., is author of a compre hensive series of articles on drug interactions. This editorial is an excerpt from the Preface of his forthcom ing Handbook of Drug Interactions which will be pub 
